Cara Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cara Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Cara Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -112 %, a 41.2% decline year-over-year.
  • Cara Therapeutics, Inc. annual Return On Assets for 2023 was -89.6 %, a 122% decline from 2022.
  • Cara Therapeutics, Inc. annual Return On Assets for 2022 was -40.4 %, a 7.79% decline from 2021.
  • Cara Therapeutics, Inc. annual Return On Assets for 2021 was -37.5 %, a 973% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -112 -32.8 -41.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -110 -44.7 -68.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -105 -61.7 -142% Jan 1, 2024 Mar 31, 2024
Q4 2023 -89.6 -49.2 -122% Oct 1, 2023 Dec 31, 2023
Q3 2023 -79.6 -40.8 -105% Jul 1, 2023 Sep 30, 2023
Q2 2023 -65.4 -36.6 -127% Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.5 -3.02 -7.46% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.4 -2.92 -7.79% Oct 1, 2022 Dec 31, 2022
Q3 2022 -38.9 -48.7 -494% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.8 -32.5 -866% Apr 1, 2022 Jun 30, 2022
Q1 2022 -40.5 -47.2 -704% Jan 1, 2022 Mar 31, 2022
Q4 2021 -37.5 -41.8 -973% Oct 1, 2021 Dec 31, 2021
Q3 2021 9.86 +63.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 3.75 +57.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 6.7 +60.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 4.3 +56.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 -53.2 -2.42 -4.76% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.6 -6.64 -14.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -53.8 -9.43 -21.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -52.1 -4.64 -9.78% Oct 1, 2019 Dec 31, 2019
Q3 2019 -50.8 +0.14 +0.28% Jul 1, 2019 Sep 30, 2019
Q2 2019 -47 +9.98 +17.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -44.4 +7.84 +15% Jan 1, 2019 Mar 31, 2019
Q4 2018 -47.4 +16 +25.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -51 +28.2 +35.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -56.9 +28.3 +33.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -52.2 +46.3 +47% Jan 1, 2018 Mar 31, 2018
Q4 2017 -63.5 +4.31 +6.36% Oct 1, 2017 Dec 31, 2017
Q3 2017 -79.2 -32.6 -69.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -85.2 -49.2 -136% Apr 1, 2017 Jun 30, 2017
Q1 2017 -98.5 -66 -203% Jan 1, 2017 Mar 31, 2017
Q4 2016 -67.8 -37.6 -124% Oct 1, 2016 Dec 31, 2016
Q3 2016 -46.6 -18.1 -63.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -36 +2.96 +7.59% Apr 1, 2016 Jun 30, 2016
Q1 2016 -32.5 -0.55 -1.72% Jan 1, 2016 Mar 31, 2016
Q4 2015 -30.2 -2.71 -9.85% Oct 1, 2015 Dec 31, 2015
Q3 2015 -28.4 +0.02 +0.07% Jul 1, 2015 Sep 30, 2015
Q2 2015 -39 Apr 1, 2015 Jun 30, 2015
Q1 2015 -32 Jan 1, 2015 Mar 31, 2015
Q4 2014 -27.5 Oct 1, 2014 Dec 31, 2014
Q3 2014 -28.5 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.